| DB ID | MyCo_2333 |
| Title | Accuracy of a Novel Histoplasmosis Enzyme Immunoassay to Evaluate Suspicious Lung Nodules |
| Year | 2019 |
| PMID | 30341097 |
| Fungal Diseases involved | Histoplasmosis |
| Associated Medical Condition | None |
| Genus | Histoplasma |
| Species | spp. |
| Organism | Histoplasma spp. |
| Ethical Statement | Patient informed consent was collected under Vanderbilt University Medical Center’s IRB (#000616). This study was approved by the Vanderbilt Institutional Review Board and conducted in accordance with the U.S. Common Rule. |
| Site of Infection | None |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Serum |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | IgM |
| Biomarker Full Name | Immunoglobulin M |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Tennessee |
| Cohort | Serum was selected from 162 patients with an IPN whose maximum diameter by CT scan was ≤30mm and who had a FDG-PET/CT scan prior to diagnosis. |
| Cohort No. | 162 |
| Age Group | None |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | ELISA |
| Analysis Method | ELISA Based |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | ELISA |
| Up Regulation Down Regulation | Positive |
| Sequence Data | None |
| External Link | None |
